The US Food and Drug Administration updated a template used to help developers provide the necessary data and information in support of a pre-emergency use authorization (EUA) submission for OTC home-use molecular or antigen diagnostic COVID-19 tests.
The “Molecular and Antigen Home Use Test Template” now includes “updated recommendations and additional clarity for test developers,” the FDA said on 9 November. The updated template also includes...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?